DGX (Quest Diagnostics Inc.) Enterprise Value-to-Revenue Coefficient

Quest Diagnostics is facing a decline in demand for PCR tests and a reduction in government payments, as illustrated by the EV/Sales multiple chart, where the 2904.47 level captures current values. The company is tackling medical waste by optimizing the transport of biomaterials. Additionally, plastic recycling systems and center energy-saving measures are being implemented to comply with environmental regulations.
Quest Diagnostics Inc. - analytical breakdowns and key metrics (DGX)

A conservative approach requires valuing the business inclusive of net debt to eliminate the impact of leverage. This indicator compares the total enterprise value to annual revenue, identifying whether the asset is overbought or undervalued. By analyzing the enterprise value-to-revenue trend, an investor can see the resilience of Quest Diagnostics (DGX), where a steady stream of test orders confirms the fundamental reliability and operational efficiency of the model.